flutamide has been researched along with Tumor Lysis Syndrome in 2 studies
Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.
Tumor Lysis Syndrome: A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanvetyanon, T | 1 |
| Choudhury, AM | 1 |
| Lin, CJ | 1 |
| Hsieh, RK | 1 |
| Lim, KH | 1 |
| Chen, HH | 1 |
| Cheng, YC | 1 |
| Wu, CJ | 1 |
2 other studies available for flutamide and Tumor Lysis Syndrome
| Article | Year |
|---|---|
Fatal acute tumor lysis syndrome, hepatic encephalopathy and flare phenomenon following combined androgen blockade.
Topics: Aged; Androgen Antagonists; Drug Therapy, Combination; Fatal Outcome; Flutamide; Goserelin; Hepatic | 2004 |
Fatal spontaneous tumor lysis syndrome in a patient with metastatic, androgen-independent prostate cancer.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Pr | 2007 |